Lilly to Acquire Morphic to Improve Outcomes ... - Eli Lilly and …
WEBJul 8, 2024 · Lilly will commence a tender offer to acquire all outstanding shares of Morphic for a purchase price of $57 per share in cash (an aggregate of approximately $3.2 billion) payable at closing. The transaction has been approved …
Lilly Completes Acquisition of Morphic to ... - Eli Lilly and Company
WEBAug 16, 2024 · Lilly's tender offer to acquire all of the issued and outstanding shares of common stock of Morphic (the "Shares"), at a purchase price of $57 per Share, net to the stockholder in cash, without interest thereon and subject to any applicable tax withholding, expired as scheduled at one minute past 11:59 p.m., Eastern time, on Aug. 15, 2024 and ...
Lilly Completes Acquisition of Morphic to Improve Outcomes and …
WEBAug 16, 2024 · Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic is a biopharmaceutical company developing oral...
Lilly to Acquire Morphic to Improve Outcomes for Patients with ...
WEBJul 8, 2024 · Lilly will commence a tender offer to acquire all outstanding shares of Morphic for a purchase price of $57 per share in cash (an aggregate of approximately $3.2 billion) payable at closing....
Eli Lilly Buys Morphic For $3.2 Billion - Forbes
WEBJul 8, 2024 · Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced Monday, a transaction that includes an experimental medication for ...
Lilly beefs up bowel disease drug portfolio with $3.2 bln Morphic …
WEBJuly 8 (Reuters) - Eli Lilly (LLY.N) agreed to buy Morphic Holding (MORF.O) for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel disease...
Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal
WEBJul 8, 2024 · Eli Lilly & Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some of the proceeds from obesity blockbuster Zepbound into its experimental pipeline.
Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Nearly
WEBLilly has agreed to pay $57 a share for Morphic, or a 79% premium to the stock’s closing price of $31.84 on Friday. The deal is expected to close in the third quarter.
Eli Lilly to pay $3.2 billion in cash to buy this biotech with an IBD ...
WEBJul 8, 2024 · Shares of Morphic Holding Inc. rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly & Co. in a cash deal valued at about $3.2 billion. Lilly...
Lilly to buy Morphic in $3B bet on inflammation drug
WEBJul 8, 2024 · Eli Lilly plans to spend $3.2 billion acquiring a Massachusetts-based biotechnology company and its experimental pill for inflammatory bowel disease. Announced Monday, the all-cash deal has Lilly buying all the outstanding shares of Morphic Therapeutics for $57 apiece — a nearly 80% premium to …